Abstract
Artificial membranes are frequently used for the development and characterization of novel dose forms such as colloidal drug delivery systems. They possess the advantage of being more reproducibly manufacturable and are often more precisely characterized relative to their properties and composition than natural membranes. In addition, they are generally much less expensive. Therefore, in a lot of cases, artificial membranes are advantageous for fundamental studies of transport mechanisms and modes of delivery of colloidal drug carriers to membranes as well as for the characterization of these carriers.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bikhazi A, Higuchi WI (1971) Interfacial barriers to the transport of sterols and other organic compounds at the aqueous polysorbate 80-hexadecane interface. Biochim Biophys Acta 233:676–687
Diepold R, Kreuter J, Himber J, Gurny R, Lee VHL, Robinson JR, Saettone MF, Schnaudigel OE (1989) Comparison of different models for the testing of pilocarpine eyedrops using conventional eyedrops and a novel depot formulation (nanoparticles). Graefes Arch Clin Exp Ophthalmol 227:188–193
Harmia T, Kreuter J, Speiser P, Boye T, Gurny R, Kubis A (1986) Enhancement of the myotic response of rabbits with pilocarpine-loaded polybutylcyanoacrylate nanoparticles. Int J Pharm 33:187–193
Karth MG, Higuchi WI, Fox JL (1985a) Direct membrane methods for the study of interface-controlled transport of cholesterol in aqueous media. J Pharm Sci 74:612–617
Karth MG, Ho NFH, Higuchi WI (1985b) Quantitative analysis of the interfacial barrier to membrane transport of cholesterol solubilized in a charged micellar system. J Pharm Sci 74:618–620
Kreuter J (1983) Evaluation of nanoparticles as drug-delivery systems: I. Preparation methods. Pharm Acta Helv 58:196–209
Kreuter J, Higuchi WI, Ganesan MG, Weiner ND (1981) Delivery of liposome membrane-associated sterols through silastic membranes. Biochim Biophys Acta 676:181–211
Kreuter J, Mills SN, Davis SS, Wilson CG (1983) Polybutylcyanoacrylate nanoparticles for the delivery of [75Se]norcholesterol. Int J Pharm 16:105–113
Papahadjopoulos D, Watkins JC (1967) Phospholipid model membranes: II. Permeability properties of hydrated liquid crystals. Biochim Biophys Acta 135:639–652
Poste C, Papahadjopoulos D (1978) The influence of vesicle membrane properties on the interaction of lipid vesicles with cultured cells. Ann NY Acad Sci 308:164–184
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Kreuter, J. (1992). Delivery of Liposome-Encapsulated Agents to Artificial Membranes. In: Braun-Falco, O., Korting, H.C., Maibach, H.I. (eds) Liposome Dermatics. Griesbach Conference. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-48391-2_16
Download citation
DOI: https://doi.org/10.1007/978-3-642-48391-2_16
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-55646-6
Online ISBN: 978-3-642-48391-2
eBook Packages: Springer Book Archive